Bronnen:
Nathan SD, Flaherty KR, Glassberg Csete MK, Raghu G, Swigris J, et al. A randomized, double-blind, placebo-controlled study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) at a dose of 30 mcg/kg-IBW/hr (iNO 30) in subjects at risk of pulmonary hypertension associated with pulmonary fibrosis (PH-PF) on long term oxygen therapy. Am J Resp Crit Care Med. 2019;199:A7354.
Nathan SD, Flaherty KR, Glassberg Csete MK, Raghu G, Swigris J, et al. A randomized, double-blind, placebo-controlled study to assess the safety and efficacy of pulsed, inhaled nitric oxide (iNO) at a dose of 30 mcg/kg-IBW/hr (iNO 30) in subjects at risk of pulmonary hypertension associated with pulmonary fibrosis (PH-PF) on long term oxygen therapy. Am J Resp Crit Care Med. 2019;199:A7354.